Growth Opportunities in European Prenatal Genetic Testing Market, Forecast to 2021

Non-invasive Prenatal Testing (NIPT) Driven by the Adoption of Next Generation Sequencing (NGS) Techniques for Screening is Driving Market Growth

USD 3,000

* Required Fields

USD 3,000

PAY BY INVOICE

Be the first to review this product

Prenatal genetic tests are predominantly used to test disorders such as aneuploidies in chromosomes 21, 18, 13 and carrier screens. They are gaining momentum in EU due to enhanced assay outcomes through non-invasive methodologies using next generation sequencing (NGS) techniques, increasing number of women choosing to undergo pregnancy at an advanced maternal age (over 35 years) and considerable popularity through social media and e-commerce channels. High level of merger and acquisition activity apart from numerous collaborations with regional clinical labs has supported the participants in marketing their products across the European region. Moreover, companies are also exploring new avenues to market their product by strategically tying up with IVF clinics, physicians, genetic counsellors and OBGYNs. Partnership with big data companies is anticipated to be the next big leap in the prenatal genetic testing market, thereby providing interpretation of vast volumes of data to increase specificity, sensitivity, and cost of tests. The key business model emerging across the market is the collaboration of key participants with regional private clinical labs as well as public centres and organizations such as NHS to increase the market coverage in Europe.


Research Scope

The key objectives of this growth insights study are to track the transformations in the prenatal genetic test market landscape in Europe for 2016-2021. The study aims at identifying growth opportunities across the market and suggesting most profitable business models to market players. Furthermore, the study provides an in-depth revenue and market analysis of 4 key segments within the prenatal landscape: NIPT, carrier screening for cystic fibrosis, invasive tests, and miscarriage tests. The study highlights industry challenges, growth drivers, restraints, competitive developments, key mergers and acquisitions (M&As), and investment opportunities. Key trends across the market with respect to physician and patient attitudes toward prenatal genetic screening and its probable impact on growth are analyzed. Additionally, top growth opportunities, profiles of game-changing companies, disruptive technologies and innovative business models, along with strategic recommendations are included.

Key Issues Addressed

  • Which are the most promising segments in the EU prenatal genetic testing market? Where is the most interest in terms of funding and innovation?
  • What are the most favorable business models across the prenatal testing market in Europe? How are companies coping with the market drawbacks and needs?
  • What are some of the most disruptive products in this market? Who are the key players in the market?
  • What are the gaps in the market that encourage penetration and provide opportunities to new entrants?

Table of Contents

1. Executive Dashboard
Purpose of This Experiential Study
5-Step Process to Transformational Growth
Scope and Segmentation
Overview of Segments
Market Engineering Measurements
2. Growth Environment—Market Overview
Methodology
Key Findings—A Highly Consolidated Market
Market Dynamics—Steady but Strong Growth
Comparison with the US Market
Impact Analysis—Key Growth Contributors
Prevalence of Foetal Chromosomal Aneuploidies
Regulatory Landscape—Most Promising Markets
Termination of Pregnancy Laws—Regional Variations
Drivers and Restraints—Technology Driven Market
Key Market Challenges
3. Growth Environment—Market Forecasts
Market Engineering Measurements
Revenue Forecast
Market Share by Type of Prenatal Genetic Tests
4. Growth Environment—Competitive Playbook
Emerging Business Models
Competitive Factors and Assessment
Key Mergers & Acquisitions and Partnerships
5. Growth Environment—Non-invasive Prenatal Testing Market
Segment Overview
Revenue Forecast
Snapshot of Key Market Participants
6. Growth Environment—Carrier Screening Tests for Cystic Fibrosis Market
7. Growth Environment—Invasive Prenatal Testing Market
8. Growth Environment—Miscarriage Testing Market
9. Visioning Scenarios
Macro to Micro Visioning
Trend Analysis in Prenatal Genetic Testing Market
10. Growth Environment and Companies to Action
Transformation in Industry Eco-system
Strategic Imperatives for Market Growth
5 Major Growth Opportunities
Growth Opportunity Matrix
11. The Last Word
Top Predictions for the EU Prenatal Genetic Testing Market
Legal Disclaimer
12. Appendix
Abbreviations and Acronyms Used
13. The Frost & Sullivan Story

Infographic



List of Figures & Charts

1. Prenatal Genetic Testing Market: Comparison with the US Market, Europe, 2016
2. Prenatal Genetic Testing Market: Regulatory Landscape, Europe, 2016
3. Prenatal Genetic Testing Market: Drivers and Restraints, Europe, 2017–2021
4. Prenatal Genetic Testing Market: Competitive Factors and Assessment, Europe, 2016
5. Prenatal Genetic Testing Market: Key Mergers & Acquisitions and Partnerships, Europe, 2016-2017


1. Prenatal Genetic Testing Market: Market Engineering Measurements, Europe, 2016
2. Prenatal Genetic Testing Market: Impact Analysis, Europe, 2016
3. Prenatal Genetic Testing Market: Prevalence of Foetal Chromosomal Aneuploidies, Europe, 2016
4. Prenatal Genetic Testing Market: Termination of Pregnancy Laws, Europe, 2016
5. Prenatal Genetic Testing Market: Key Market Challenges, Europe, 2016
6. Prenatal Genetic Testing Market: Market Engineering Measurements, Europe, 2016
7. Prenatal Genetic Testing Market: Revenue Forecast, Europe, 2016–2021
8. Prenatal Genetic Testing Market: Market Share Analysis by Tests, Europe, 2016
9. Prenatal Genetic Testing Market: Market Share Analysis by Tests, Europe, 2021
10. Prenatal Genetic Testing Market: Emerging Business Models, Europe, 2016-2021
11. Non-invasive Prenatal Testing Market: Revenue Forecast, Europe, 2016–2021
12. Non-invasive Prenatal Testing Market: Snapshot of Key Market Participants, Europe, 2016
13. Carrier Screening Test for Cystic Fibrosis Market: Revenue Forecast, Europe, 2016–2021
14. Carrier Screening Tests for Cystic Fibrosis Market: Snapshot of Key Market Participants, Europe, 2016
15. Invasive Prenatal Testing Market: Revenue Forecast, Europe, 2016–2021
16. Invasive Prenatal Testing Market: Snapshot of Key Market Participants, Europe, 2016
17. Miscarriage Testing Market: Revenue Forecast, Europe, 2016–2021
18. Miscarriage Testing Market: Snapshot of Key Market Participants, Europe, 2016
19. Prenatal Genetic Testing Market: Trend Analysis, Europe, 2016-2021
20. Prenatal Genetic Testing Market: Growth Opportunity Matrix, Europe, 2016



Keyword1

Keyword2

Keyword3

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.